Laurent Fauchier1, Arnaud Bisson2, Alexandre Bodin2, Julien Herbert2,3, Denis Angoulvant2, Nicolas Danchin4, Yves Cottin5. 1. Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, EA7505, Hôpital Trousseau, Université de Tours, 37044, Tours, France. lfau@univ-tours.fr. 2. Service de Cardiologie, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, EA7505, Hôpital Trousseau, Université de Tours, 37044, Tours, France. 3. Service d'information médicale, d'épidémiologie et d'économie de la santé, Centre Hospitalier Universitaire et Faculté de Médecine, EA7505, Université de Tours, Tours, France. 4. Service de Cardiologie, Hôpital Européen Georges Pompidou, Assistance-Publique Hôpitaux de Paris, Université Paris Descartes, Paris, France. 5. Service de Cardiologie, Centre Hospitalier Universitaire et Faculté de Médecine, Université de Dijon, Dijon, France.
Abstract
BACKGROUND: In patients with acute myocardial infarction (AMI), history of atrial fibrillation (AF) and new onset AF during the early phase may be associated with a worse prognosis. Whether both conditions are associated with similar outcomes is a matter of debate. METHODS: We collected information for all patients with AMI seen in French hospitals between 2010 and 2019. Among 797,212 patients seen with STEMI or NSTEMI, 75,701 (9.5%) had history of AF, and 34,768 (4.4%) had new AF diagnosed between day 1 and day 30 after AMI. RESULTS: Patients with new AF were older and had more comorbidities than those with no AF but were younger and had less comorbidities than those with history of AF. During follow-up [mean (SD) 1.8 (2.4) years, median (interquartile range) 0.7 (0.1-3.1) years], 163,845 deaths and 30,672 ischemic strokes were recorded. Using Cox multivariable analysis, compared to patients with no AF, history of AF was associated with a higher risk of death during follow-up (adjusted hazard ratio HR 1.17, 95% CI 1.16-1.19) and this was also the case for patients with new AF (adjusted HR 2.11, 2.07-2.15). Both history of AF and new AF were associated with a higher risk of ischemic stroke compared to patients with no AF: adjusted HR 1.19 (1.15-1.23) for history of AF, adjusted HR 1.78 (1.68-1.88) for new AF. New AF was associated with a higher risk of death and of ischemic stroke than history of AF: adjusted HR 1.74 (1.70-1.79) and 1.32 (1.23-1.42), respectively. CONCLUSIONS: In a large and systematic nationwide analysis, AF first recorded in the first 30 days after AMI was independently associated with higher risks of death and ischemic stroke than those in patients with no AF or previously known AF.
BACKGROUND: In patients with acute myocardial infarction (AMI), history of atrial fibrillation (AF) and new onset AF during the early phase may be associated with a worse prognosis. Whether both conditions are associated with similar outcomes is a matter of debate. METHODS: We collected information for all patients with AMI seen in French hospitals between 2010 and 2019. Among 797,212 patients seen with STEMI or NSTEMI, 75,701 (9.5%) had history of AF, and 34,768 (4.4%) had new AF diagnosed between day 1 and day 30 after AMI. RESULTS: Patients with new AF were older and had more comorbidities than those with no AF but were younger and had less comorbidities than those with history of AF. During follow-up [mean (SD) 1.8 (2.4) years, median (interquartile range) 0.7 (0.1-3.1) years], 163,845 deaths and 30,672 ischemic strokes were recorded. Using Cox multivariable analysis, compared to patients with no AF, history of AF was associated with a higher risk of death during follow-up (adjusted hazard ratio HR 1.17, 95% CI 1.16-1.19) and this was also the case for patients with new AF (adjusted HR 2.11, 2.07-2.15). Both history of AF and new AF were associated with a higher risk of ischemic stroke compared to patients with no AF: adjusted HR 1.19 (1.15-1.23) for history of AF, adjusted HR 1.78 (1.68-1.88) for new AF. New AF was associated with a higher risk of death and of ischemic stroke than history of AF: adjusted HR 1.74 (1.70-1.79) and 1.32 (1.23-1.42), respectively. CONCLUSIONS: In a large and systematic nationwide analysis, AF first recorded in the first 30 days after AMI was independently associated with higher risks of death and ischemic stroke than those in patients with no AF or previously known AF.
Authors: S S Rathore; A K Berger; K P Weinfurt; K A Schulman; W J Oetgen; B J Gersh; A J Solomon Journal: Circulation Date: 2000-03-07 Impact factor: 29.690
Authors: J Bezin; A Pariente; R Lassalle; C Dureau-Pournin; A Abouelfath; P Robinson; N Moore; C Droz-Perroteau; A Fourrier-Reglat Journal: Eur J Clin Pharmacol Date: 2013-11-24 Impact factor: 2.953
Authors: Patricia Jabre; Xavier Jouven; Frédéric Adnet; Gabriel Thabut; Suzette J Bielinski; Susan A Weston; Véronique L Roger Journal: Circulation Date: 2011-05-02 Impact factor: 29.690
Authors: Dennis H Lau; Luan T Huynh; Derek P Chew; Carolyn M Astley; Ashish Soman; Prashanthan Sanders Journal: Am J Cardiol Date: 2009-09-25 Impact factor: 2.778
Authors: Karl J Weiss; Sarah B Nasser; Tamar Bigvava; Adelina Doltra; Bernhard Schnackenburg; Alexander Berger; Markus S Anker; Christian Stehning; Patrick Doeblin; Mohamed Abdelmeguid; Mohamed Talat; Rolf Gebker; Wael E-Naggar; Burkert Pieske; Sebastian Kelle Journal: ESC Heart Fail Date: 2021-12-06
Authors: Stephan Camen; Dora Csengeri; Bastiaan Geelhoed; Teemu Niiranen; Francesco Gianfagna; Julie K Vishram-Nielsen; Simona Costanzo; Stefan Söderberg; Erkki Vartiainen; Christin S Börschel; Maria Benedetta Donati; Maja-Lisa Løchen; Francisco M Ojeda; Jukka Kontto; Ellisiv B Mathiesen; Steen Jensen; Wolfgang Koenig; Frank Kee; Giovanni de Gaetano; Tanja Zeller; Torben Jørgensen; Hugh Tunstall-Pedoe; Stefan Blankenberg; Kari Kuulasmaa; Allan Linneberg; Veikko Salomaa; Licia Iacoviello; Renate B Schnabel Journal: J Am Heart Assoc Date: 2022-03-24 Impact factor: 6.106